Grace Therapeutics, Inc.
GRCE· Nasdaq
GRCEGrace Therapeutics, Inc.
Filed Aug 12, 2021 · 10-Q · 43 days after period end · 0001171843-21-005871
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Net Income | -$3.12M | -$4.67M | -$8.85M |
| EPS Diluted | -$0.12 | -$0.05 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Grace Therapeutics, Inc. · CIK 1444192 · Engraved from SEC EDGAR
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end
